Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature
ConclusionsOur study reveals promising improvement of premature ovarian failure –related clinical manifestations in two patients after intraovarian autologous bone marrow–derived mesenchymal stem cells engraftment. These early observations call for additional assessment and further development of intraovarian bone marrow–derived mesenchymal stem cell injection for possibl e treatment of patients with premature ovarian failure.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Amenorrhea | Chemotherapy | General Medicine | Hormones | Infertility | Laparoscopy | Men | Menopause | Ovaries | Pregnancy | Reproduction Medicine | Stem Cell Therapy | Stem Cells | Study | Ultrasound | Women